Eledon Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €34.00M +584.8% -€87.10M -25.6% -256.1% +21 pp N/A N/A
    (estimated) €4.97M +∞% -€117.08M +10.9% -2,357.9% -24 pp N/A N/A
    (estimated) €0.00 +NaN% -€105.54M +22.9% N/A N/A N/A
    (estimated) €0.00 +NaN% -€85.90M +66.7% N/A N/A N/A
    (estimated) €0.00 +NaN% -€51.55M +70.5% N/A N/A N/A
    €0.00 +NaN% -€30.24M -12.4% N/A -€40.47M +19.6% N/A
    €0.00 +NaN% -€34.52M -53.9% N/A -€33.84M +39.1% N/A
    €0.00 +NaN% -€74.91M +153.6% N/A -€24.33M -1.7% N/A
    €0.00 -100.0% -€29.54M +51.3% N/A -€24.75M +90.1% N/A
    €102.73K +∞% -€19.53M +27.6% -19,009.2% -190 pp -€13.02M +9.8% -12,676.7% -130 pp
    €0.00 +NaN% -€15.31M +27.1% N/A -€11.86M +16.5% N/A
    €0.00 +NaN% -€12.04M +7.2% N/A -€10.18M -20.4% N/A
    €0.00 +NaN% -€11.23M -65.4% N/A -€12.79M -59.1% N/A
    €0.00 +NaN% -€32.50M -15.8% N/A -€31.25M -10.2% N/A
    €0.00 +NaN% -€38.60M +93.5% N/A -€34.82M +92.8% N/A
    €0.00 +NaN% -€19.94M +48.1% N/A -€18.06M +36.5% N/A
    €0.00 +NaN% -€13.46M +63.0% N/A -€13.23M +65.7% N/A
    €0.00 -€8.26M N/A -€7.98M N/A

    Notifications